Immunome, Inc. (IMNM)
NASDAQ: IMNM · IEX Real-Time Price · USD
14.27
-0.39 (-2.66%)
At close: Apr 24, 2024, 4:00 PM
14.42
+0.15 (1.05%)
After-hours: Apr 24, 2024, 4:34 PM EDT
Immunome Market Cap
Immunome has a market cap or net worth of $609.75 million as of April 24, 2024. Its market cap has increased by 807.37% in one year.
Market Cap
609.75M
Enterprise Value
473.01M
1-Year Change
807.37%
Ranking
Category
Stock Price
$14.27
Market Cap Chart
Since the IPO on October 2, 2020, Immunome's market cap has increased from $111.39M to $609.75M, an increase of 447.40%. That is a compound annual growth rate of 61.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2024 | 875.10M | -4.06% |
| Apr 22, 2024 | 912.10M | -1.30% |
| Apr 19, 2024 | 924.10M | -9.89% |
| Apr 18, 2024 | 1.03B | -1.16% |
| Apr 17, 2024 | 1.04B | -5.54% |
| Apr 16, 2024 | 1.10B | -2.38% |
| Apr 15, 2024 | 1.13B | -8.41% |
| Apr 12, 2024 | 1.23B | -2.10% |
| Apr 11, 2024 | 1.25B | 3.39% |
| Apr 10, 2024 | 1.21B | -0.73% |
| Apr 9, 2024 | 1.22B | 1.69% |
| Apr 8, 2024 | 1.20B | -0.60% |
| Apr 5, 2024 | 1.21B | - |
| Apr 4, 2024 | 1.21B | -6.20% |
| Apr 3, 2024 | 1.29B | 0.98% |
| Apr 2, 2024 | 1.28B | -3.25% |
| Apr 1, 2024 | 1.32B | -10.42% |
| Mar 28, 2024 | 1.47B | 35.10% |
| Mar 27, 2024 | 1.09B | 0.52% |
| Mar 26, 2024 | 1.08B | 5.79% |
| Mar 25, 2024 | 1.03B | -1.32% |
| Mar 22, 2024 | 1.04B | 0.75% |
| Mar 21, 2024 | 1.03B | 0.09% |
| Mar 20, 2024 | 1.03B | 0.17% |
| Mar 19, 2024 | 1.03B | 8.96% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 706.88B |
| Novo Nordisk | 565.69B |
| UnitedHealth Group | 449.55B |
| Johnson & Johnson | 362.21B |
| Merck & Co. | 321.70B |
| AbbVie | 301.19B |
| AstraZeneca | 220.03B |
| Thermo Fisher | 219.59B |